Yahoo! Finance Search - Finance Home - Yahoo! - Help

Wednesday, May 4 2016 12:19am ET - U.S. Markets open in 9 hours and 11 minutes.
Industry Center - Drug Related Products
Industry Center > Drug Related Products > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Related Products News
Latest News
Tuesday, May 3, 2016
·USANA Health Sciences Reports First Quarter Financial Results
Business Wire - 2 minutes ago
·Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex® 1200mg DM Extended-Release Tablets
PR Newswire - Tue 8:53 am ET
·CTD Holdings to Present "Management of Niemann-Pick Type C With Intravenous Hydroxypropyl- b -Cyclodextrin" at Ara Parseghian Medical Research Foundation Annual Conference
Marketwire - Tue 7:00 am ET
Monday, May 2, 2016
·Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin® Pump Topical Gel
PR Newswire - Mon 9:02 am ET
Sunday, May 1, 2016
·Short Sellers Target Perrigo After CEO Exit as Goldman Says Sell
at Bloomberg - Sat Apr 30
Friday, Apr 29, 2016
·Valeant Files Much Delayed Annual Earnings Saying It’s “Cured”
at Fortune - Fri Apr 29
Thursday, Apr 28, 2016
·Here’s how much money it took for Perrigo’s ex-CEO to leave for Valeant
at MarketWatch - Thu Apr 28
·Top Colombian Soccer Teams Partner With USANA Health Sciences
PR Newswire - Thu Apr 28
·Perrigo Expands the Responsibilities of Sharon Kochan, Perrigo's Executive Vice President and General Manager, International, to Lead the Branded Consumer Healthcare Segment
PR Newswire - Thu Apr 28
·Valeant to name four new directors as soon as Friday -WSJ
Reuters - Wed Apr 27
·[$$] Valeant's Pearson Admits Aggressive Drug-Price Increases Were a Mistake
at The Wall Street Journal Online - Wed Apr 27
·Valeant Discloses Pay for New CEO
at The Wall Street Journal Online - Wed Apr 27
·[$$] Bill Ackman admits fault in Valeant investment
at FT.com - Wed Apr 27
·Valeant CEO tells Senate committee drug price increases were too aggressive
at MarketWatch - Wed Apr 27
·Ackman, Valeant pledge reforms after spiking drug prices
Reuters - Wed Apr 27
·Valeant to pay new CEO Papa base salary of $1.5 mln
Reuters - Wed Apr 27
·Bill Ackman: Valeant’s Drug Price Hikes Hurt America
at Fortune - Wed Apr 27
Wednesday, Apr 27, 2016
·Valeant CEO to tell U.S. Senate he regrets raising heart drug prices
Reuters - Wed Apr 27
Tuesday, Apr 26, 2016
·Is There Any Hope for Perrigo Stock?
at TheStreet.com - Tue Apr 26
·A.M. Funds Roundup: Time To Simplify Your Fund Portfolio?
at Barrons.com - Tue Apr 26
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Related Products Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?